Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2026)

Fulgent Genetics (FLGT) has 8 years of Other Accumulated Expenses data on file, last reported at $2.5 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 42.04% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 42.04% YoY) and the FY2025 annual result came in at $2.8 million, down 21.66% from the prior year.
• Other Accumulated Expenses slipped to $2.5 million in Q1 2026 per FLGT's latest filing, from $2.8 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $13.6 million in Q3 2022, with the low at $281000.0 in Q3 2023.
• Average Other Accumulated Expenses over 5 years is $3.7 million, with a median of $3.6 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses slumped 97.94% in 2023 and soared 1345.55% in 2024.
• Fulgent Genetics' Other Accumulated Expenses stood at $2.1 million in 2022, then jumped by 97.52% to $4.2 million in 2023, then slipped by 13.78% to $3.6 million in 2024, then slipped by 21.66% to $2.8 million in 2025, then retreated by 13.07% to $2.5 million in 2026.
• Business Quant data shows FLGT's Other Accumulated Expenses at $2.5 million in Q1 2026, $2.8 million in Q4 2025, and $6.9 million in Q3 2025.